Palliative Care Unit Transfert Announcements

NCT ID: NCT03139188

Last Updated: 2017-05-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

10 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-05-02

Study Completion Date

2018-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The course of care of a patient with a cancer whose evolution is pejorative, is marked by difficult announcements, called "bad news". In the palliative phase, prognostic announcements are at the forefront. Of these, the announcement of a transfer to the Palliative Care Unit has not been the subject of any specific studies to the best of our knowledge. It therefore seemed interesting to us to explore the stakes of this particular announcement, a source of upheaval for the doctor and the patient, by gathering the point of view of each one.

The objective of our study is to analyze the methods of announcing a transfer to the Palliative Care Unit and the perception of this announcement by the doctor and his patient with an incurable cancer.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients over 18 years old with solid cancer or malignant haemopathy in palliative phase transferred from a HUS service to the HUS UnASP and informed of this transfer by the originating doctor .

HUS senior hospital doctors, supporting patients with solid cancers or malignant hemopathies.

Exclusion Criteria

* Patients whose clinical state does not allow for maintenance (tiredness, confusion) or difficult communication.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Strasbourg, France

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Virginie LEROY, MD

Role: STUDY_DIRECTOR

University Hospital, Strasbourg, France

Laurent CALVEL, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

University Hospital, Strasbourg, France

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Service : Unité de soins d'Accompagnement de soins de Support et de soins Palliatifs (UnASP)

Strasbourg, , France

Site Status NOT_YET_RECRUITING

Service : Unité de soins d'Accompagnement de soins de Support et de soins Palliatifs (UnASP)

Strasbourg, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Virginie LEROY, MD

Role: CONTACT

03 88 11 65 84

Laurent CALVEL, MD, PhD

Role: CONTACT

33 3 88 11 52 66

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Virginie LEROY, MD

Role: primary

03 88 11 65 84

Laurent CALVEL, MD, PhD

Role: backup

33 3 88 11 52 66

Virginie Leroy, MD

Role: primary

03 88 11 65 84

Laurent CALVEL, MD, PhD

Role: backup

03 88 11 52 66

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

6789

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.